AI-Based Prediction of Liver Metastasis in Colorectal Cancer (A Retrospective Study)
Recruiting
Observational Study
Colorectal Cancer Liver Metastases (CRLM)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,500 (estimated)
- Sponsor
- Tongji Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This multicenter, retrospective study aims to develop and validate a multimodal deep learning model for predicting the risk of metachronous liver metastasis in patients with stage I-III colorectal cancer following curative resection. The model will integrate preoperative contrast-enhanced CT imaging, digitized histopathological whole-slide images, and standard clinical-pathological data.
The prim…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18-75 years, any gender.
* Histologically confirmed primary colon or rectal adenocarcinoma.
* Underwent curative radical resection (R0 resection) for colorectal cancer.
* Preoperative contrast-enhanced abdominal/pelvic CT scan performed within 1 month before surgery, with …
Contacts